O56 SOFOSBUVIR/LEDIPASVIR WITH AND WITHOUT RIBAVIRIN FOR 8 WEEKS COMPARED TO SOFOSBUVIR/LEDIPASVIR FOR 12 WEEKS IN TREATMENT-NAÏVE NON-CIRRHOTIC GENOTYPE-1 HCV-INFECTED PATIENTS: THE PHASE 3 ION-3 STUDY
Authors:
- K.V. KowdleyKKK.V. Kowdley
- G.C. StuartGSG.C. Stuart
- R.K. ReddyRRR.K. Reddy
- L. RossaroLRL. Rossaro
- D.E. BernsteinDBD.E. Bernstein
- D. AnDAD. An
- E.S. SvarovskaiaESE.S. Svarovskaia
- R.H. HylandRHR.H. Hyland
- P.S. PangPPP.S. Pang
- W.T. SymondsWSW.T. Symonds
- J.G. MchutchisonJMJ.G. Mchutchison
- A.J. MuirAMA.J. Muir
- 1 April 2014
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S23-S24